TFS CAPITAL LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 167 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$334,000
+136.9%
33,809
+107.6%
0.09%
+242.3%
Q2 2016$141,000
-18.5%
16,286
-11.1%
0.03%
+4.0%
Q1 2016$173,000
-54.8%
18,310
-35.8%
0.02%
-32.4%
Q3 2015$383,000
-81.9%
28,503
-80.8%
0.04%
-82.1%
Q1 2015$2,116,000
+1013.7%
148,179
+610.2%
0.21%
+1193.8%
Q3 2014$190,000
-53.4%
20,864
-23.4%
0.02%
-15.8%
Q4 2013$408,000
-74.8%
27,247
-81.4%
0.02%
-74.3%
Q3 2013$1,616,000
+32.5%
146,416
-4.6%
0.07%
+45.1%
Q2 2013$1,220,000153,4320.05%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders